RN-VT Outcomes for Patients With Renal Cell Carcinoma
Following radical nephrectomy and venous thrombectomy (RN-VT), patients with renal cell carcinoma...
Read More
Dissemination (Spotlight)
Metastatic Renal Cell Carcinoma Outcomes Linked With CT Texture Analysis
In metastatic renal cell carcinoma (mRCC), immune checkpoint inhibitor treatment responses vary,...
Read More
Gynecologic Cancer Survival Impacted By Race
Across histologies other than clear cell, Black women with stage 1 endometrial cancer experienced...
Read More
Renal Cell Carcinoma & Deep Invasive Tumor Thrombus: Predicting Surgical Complications
Radical nephrectomy and thrombectomy can effectively improve the prognosis of the 4% to 10% of...
Read More
Sub-Lobar Resection Good For Geriatric Patients With eNSCLC
While thoracoscopic sub-lobar resection (SR) appears to result in similar oncologic outcomes...
Read More
Preoperative PET/CT Predicts Uterine Tumor Characteristics
Preoperative PET/CT provided information on standardized uptake value (SUV) and volumetric...
Read More
Assessing Telehealth for the Outpatient Management of Heart Failure
The burden of stay-at-home mandates resulting from COVID-19 and the hesitancy of people to leave...
Read More
Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
In this study, bioinformatics methods were performed to screen the candidate prognosis-related...
Read More
Aberrant Lipid Metabolism ID’d in Early-Stage Lung Cancer
THURSDAY, Feb. 3, 2022 (HealthDay News) — A plasma assay that detects dysregulated lipids...
Read MorePembrolizumab Bests TKIs for Treating High-Risk Renal Cell Carcinoma
A study published in the European Urology Oncology reports superior oncologic and safety benefits of adjuvant pembrolizumab compared with adjuvant tyrosine kinase inhibitors (TKIs) in patients treated with nephrectomy for...
Read MoreApigenin inhibits renal cell carcinoma cell proliferation through G2/M phase cell cycle arrest.
Apigenin is a flavonoid widely presented in fruits and vegetables, and is known to possess anti‑inflammatory, antioxidant, and anticancer properties. The present study was designed to investigate the effects of apigenin on renal...
Read More
Higher Coffee Consumption Tied to Lower Risk for Uterine Cancer
FRIDAY, Jan. 28, 2022 (HealthDay News) — Increased coffee intake is associated with a lower...
Read MoreA Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression.
. Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a rare aggressive renal malignancy associated with hereditary leiomyomatosis and RCC syndrome (HLRCC). Tumors exhibiting heterogeneous (ie, patchy) FH loss by...
Read More
Diagnosing Patients with Early-Stage Non-Small Cell Lung Cancer (NSCLC) and the Recommended Course of Action
A research exhibited the contemporary approved approaches for the workup required to diagnose...
Read More
Real-World Outcomes in Advanced Gynecologic Cancer
Women with advanced/recurrent endometrial cancer, especially those with the non-endometrioid (type...
Read MorePatient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial.
In the CheckMate 9ER trial, patients with advanced renal cell carcinoma who received first-line nivolumab plus cabozantinib had significantly better progression-free survival compared with those given sunitinib. In this study,...
Read MoreTime to Treatment Initiation: Effects For Patients With Non–Small-Cell Lung Cancer
For a study, the researchers wanted to determine how time from diagnosis to treatment (TTI) affected viability in patients with non-metastatic non–small-cell lung cancer (NSCLC). Between 2004 and 2013, the National Cancer...
Read MoreIbrutinib Continues to Outperform Chemoimmunotherapy in Patients With Treatment-Naïve CLL
Ibrutinib was associated with prolonged progression-free survival (PFS) compared to the chemoimmunotherapy regimen bendamustine plus rituximab in older patients with treatment-naïve chronic lymphocytic leukemia (CLL). In...
Read MoreRenal Cell Carcinoma and Other Renal Masses in Kidney Graft Patients
Renal masses in kidney grafts provide a difficult clinical problem, as they must balance graft function with the necessity for cancer management. Cancers in the renal graft caused by donors can be classed as either ‘donor...
Read MoreMicroRNAs in The Urine: A Potential New Tool for Renal Cancer Diagnosis, Prognosis, and Monitoring
Renal cell carcinoma is the third most prevalent kind of urologic cancer. Because the first symptoms are often vague and late, the phases are often advanced when detected. As compensation, the discovery of RCC by abdominal...
Read More